List of Tables
    Table 1. Anti-Viral Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anti-Viral Drugs Market Trends
    Table 3. Anti-Viral Drugs Market Drivers
    Table 4. Anti-Viral Drugs Market Challenges
    Table 5. Anti-Viral Drugs Market Restraints
    Table 6. Global Anti-Viral Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti-Viral Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti-Viral Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti-Viral Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti-Viral Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti-Viral Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anti-Viral Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anti-Viral Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Anti-Viral Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anti-Viral Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Anti-Viral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti-Viral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Viral Drugs as of 2021)
    Table 18. Top Players of Anti-Viral Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anti-Viral Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Anti-Viral Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anti-Viral Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anti-Viral Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anti-Viral Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anti-Viral Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Anti-Viral Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anti-Viral Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anti-Viral Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Anti-Viral Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Anti-Viral Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anti-Viral Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anti-Viral Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Anti-Viral Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anti-Viral Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Anti-Viral Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anti-Viral Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Anti-Viral Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anti-Viral Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Anti-Viral Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anti-Viral Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Anti-Viral Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. F. Hoffmann-La Roche Corporation Information
    Table 43. F. Hoffmann-La Roche Description and Business Overview
    Table 44. F. Hoffmann-La Roche Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. F. Hoffmann-La Roche Anti-Viral Drugs Product
    Table 46. F. Hoffmann-La Roche Recent Development
    Table 47. GlaxoSmithKline Corporation Information
    Table 48. GlaxoSmithKline Description and Business Overview
    Table 49. GlaxoSmithKline Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. GlaxoSmithKline Product
    Table 51. GlaxoSmithKline Recent Development
    Table 52. Bristol-Myers-Squibb Corporation Information
    Table 53. Bristol-Myers-Squibb Description and Business Overview
    Table 54. Bristol-Myers-Squibb Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Bristol-Myers-Squibb Product
    Table 56. Bristol-Myers-Squibb Recent Development
    Table 57. AbbVie Corporation Information
    Table 58. AbbVie Description and Business Overview
    Table 59. AbbVie Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. AbbVie Product
    Table 61. AbbVie Recent Development
    Table 62. Johnson & Johnson Corporation Information
    Table 63. Johnson & Johnson Description and Business Overview
    Table 64. Johnson & Johnson Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Johnson & Johnson Product
    Table 66. Johnson & Johnson Recent Development
    Table 67. Merck & Co Corporation Information
    Table 68. Merck & Co Description and Business Overview
    Table 69. Merck & Co Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Merck & Co Product
    Table 71. Merck & Co Recent Development
    Table 72. Aurobindo Pharma Corporation Information
    Table 73. Aurobindo Pharma Description and Business Overview
    Table 74. Aurobindo Pharma Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Aurobindo Pharma Product
    Table 76. Aurobindo Pharma Recent Development
    Table 77. Cipla Corporation Information
    Table 78. Cipla Description and Business Overview
    Table 79. Cipla Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Cipla Product
    Table 81. Cipla Recent Development
    Table 82. Dr Reddy’s Corporation Information
    Table 83. Dr Reddy’s Description and Business Overview
    Table 84. Dr Reddy’s Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Dr Reddy’s Product
    Table 86. Dr Reddy’s Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Anti-Viral Drugs Customers List
    Table 90. Anti-Viral Drugs Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Viral Drugs Product Picture
    Figure 2. Global Anti-Viral Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti-Viral Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anti-Viral Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Anti-Viral Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anti-Viral Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anti-Viral Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Anti-Viral Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anti-Viral Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Anti-Viral Drugs Report Years Considered
    Figure 11. Product Picture of Nucleotide Polymerase Inhibitor
    Figure 12. Product Picture of Reverse Transcriptase Inhibitor
    Figure 13. Product Picture of Protease Inhibitor
    Figure 14. Global Anti-Viral Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Anti-Viral Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Anti-Viral Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Anti-Viral Drugs Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Anti-Viral Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Anti-Viral Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Anti-Viral Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Anti-Viral Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Anti-Viral Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Anti-Viral Drugs Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Anti-Viral Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Anti-Viral Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of HIV
    Figure 27. Product Picture of Hepatitis
    Figure 28. Product Picture of HSV
    Figure 29. Product Picture of Influenza
    Figure 30. Global Anti-Viral Drugs Market Share by Application in 2022 & 2028
    Figure 31. Global Anti-Viral Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Anti-Viral Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Anti-Viral Drugs Sales by Application (2017-2028) & (K Units)
    Figure 34. Global Anti-Viral Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Anti-Viral Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Anti-Viral Drugs Market Share by Application in 2022 & 2028
    Figure 37. United States Anti-Viral Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Anti-Viral Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Anti-Viral Drugs Sales by Application (2017-2028) & (K Units)
    Figure 40. United States Anti-Viral Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Anti-Viral Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Anti-Viral Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 43. North America Anti-Viral Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Anti-Viral Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. Europe Anti-Viral Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Anti-Viral Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 54. Asia-Pacific Anti-Viral Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Anti-Viral Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 66. Latin America Anti-Viral Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Anti-Viral Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 71. Middle East & Africa Anti-Viral Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Anti-Viral Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Anti-Viral Drugs Value Chain
    Figure 76. Anti-Viral Drugs Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed